<DOC>
	<DOCNO>NCT01063270</DOCNO>
	<brief_summary>The purpose research study evaluate efficacy two treatment regimen treatment hidradenitis suppurativa . This randomize control study . Patients randomly assign arm study .</brief_summary>
	<brief_title>Trial Comparing Efficacy Treatments Hidradenitis Suppurativa</brief_title>
	<detailed_description>Histological study suggest HS disease follicle apocrine involvement secondary event . The investigator identify previous study Nd Yag laser highly effective decrease inflammation , pain , suppuration frequency recurrence HS . Oral antibiotic therapy Clindamycin Rifampin also report previous study highly effective treatment regimen HS commonly use physician medical management HS . The investigator would like compare efficacy NdYag laser treatment combine antibiotic versus treatment antibiotic alone . The goal evaluate success two treatment regimen existent HS lesion well prevention recurrence . There approximately 18 people research study Henry Ford Health System ( HFHS ) .</detailed_description>
	<mesh_term>Hidradenitis</mesh_term>
	<mesh_term>Hidradenitis Suppurativa</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>1 . Be least 16 year old weigh minimum 80lbs . Weight requirement purpose maintain safe clindamycin rifampin dose regimen . 2 . Be otherwise healthy 3 . Have diagnosis HS 4 . Patients must Hurley stage II HS , one widely separate recurrent abscess , tract scar . Involvement bilateral symmetric axilla , inguinal region inframammary region 5 . Agree abide Investigator 's guideline regard photosensitize drug 6 . Be able understand requirement study , risk involve , able sign inform consent form 7 . Agree follow undergo studyrelated procedure 1 . Patients HS Hurley stage I III exclude participation study 2 . Patients currently pregnant able take part study due unknown effect antibiotic 3 . Concomitant use systemic topical treatment HS involve current study . Patients must discontinue form oral therapy systemic topical antibiotic retinoids 2 week prior start treatment 4 . Exacerbation patient 's original condition express clinically shift Hurley Stage II Stage III 5 . Patient unable take antibiotic therapy 6 . Any reason investigator feel patient participate study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Hidradenitis Suppurativa</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Laser</keyword>
</DOC>